|
|
|
|
Explore how NK cells and TILs offer new hope for cancer treatment, potentially overcoming the scalability and safety challenges of current CAR-T cell therapies. Learn about the distinct advantages and manufacturing hurdles of these next-generation immunotherapies.
|
|
|
|
|
Multispecific antibodies are a newer class of cancer therapeutics addressing tumor complexity. Learn about the design, manufacturing, and regulatory challenges and integrated solutions accelerating their development.
|
|
|
|
|
Discover how a superior cell culture media supplier provides a VIP experience through seamless ordering, proactive demand planning, and customization to accelerate your project to market.
|
|
|
|
|
Industry 5.0 represents the next generation of bioproduction—the Adaptive Plant—where human expertise is empowered by AI-enabled insights, autonomous systems, and strategic collaboration.
|
|
|
